73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer

Minimally invasive, cost-effective method shows promise in treating cancer without harming healthy cells

by Purdue UniversityA Purdue innovation, called PLASMAT, combines three emerging techniques that appear promising in the fight against most types of cancer. Credit: Purdue UniversityPurdue Univer
Drug combination shows potential in aggressive leukemia

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in
Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin
Researchers study cost-effectiveness of rectal cancer treatments

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo

Researchers study cost-effectiveness of rectal cancer treatments

by Duane Bates,University of California, Los AngelesUCLA radiation therapists review a patient’s plan before setting the patient up for treatment. Credit: University of California, Los AngelesCo
Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh
Researchers trace timeline of tumor evolution in metastatic breast cancer patients

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.
Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura
How post-feeding breasts bounce back from the brink of death to kick-start milk production

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation
Study suggests improved time efficiency, accuracy with AI-automated head and neck radiotherapy model

Study suggests improved time efficiency, accuracy with AI-automated head and neck radiotherapy model

byMayo Clinic3D visualization, and an axial and sagittal slice of the CT with the contours from the gold standard (GS) dataset, as well as the DL, DL+RO, and MDA+RO contours for a representative

Study suggests improved time efficiency, accuracy with AI-automated head and neck radiotherapy model

byMayo Clinic3D visualization, and an axial and sagittal slice of the CT with the contours from the gold standard (GS) dataset, as well as the DL, DL+RO, and MDA+RO contours for a representative
A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)
New circulating tumor DNA test measures multiple markers to detect cancer early

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l
Study shows many expensive cancer drugs have unclear patient benefit

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid